Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-23 Sale |
2022-09-27 6:14 pm |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Director |
11,100 | $6.4001 | $71,041 | 3,956,734 (Indirect Direct) |
View |
| 2021-06-21 Purchase |
2021-06-23 5:33 pm |
Lyell Immunopharma Inc. | LYEL | FRIEDMAN CATHY Director |
17,648 | $17 | $300,016 | 117,648 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-16 Option Award |
2023-06-20 4:47 pm |
N/A 2033-06-15 |
Lyell Immunopharma Inc. | LYEL | NABEL ELIZABETH G Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 4:45 pm |
N/A 2033-06-15 |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Director |
65,000 | $0 | 4,021,734 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 4:43 pm |
N/A 2033-06-15 |
Lyell Immunopharma Inc. | LYEL | FRIEDMAN CATHY Director |
65,000 | $0 | 401,370 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 4:41 pm |
N/A 2033-06-15 |
Lyell Immunopharma Inc. | LYEL | BRAWLEY OTIS W Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 4:40 pm |
N/A 2033-06-15 |
Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director |
65,000 | $0 | 4,750,614 (Direct) |
View |
| 2023-02-24 Option Award |
2023-02-28 6:21 pm |
N/A 2033-02-23 |
Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Technical Ops. Officer |
900,000 | $0 | 902,941 (Direct) |
View |
| 2023-02-24 Option Award |
2023-02-28 6:19 pm |
N/A 2033-02-23 |
Lyell Immunopharma Inc. | LYEL | Albertson Tina M. Chief Medical Officer |
700,000 | $0 | 704,049 (Direct) |
View |
| 2023-02-24 Option Award |
2023-02-28 6:17 pm |
N/A 2033-02-23 |
Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer |
600,000 | $0 | 604,702 (Direct) |
View |
| 2023-02-24 Option Award |
2023-02-28 6:15 pm |
N/A 2033-02-23 |
Lyell Immunopharma Inc. | LYEL | Thompson Rahsaan Chief Legal Officer |
245,000 | $0 | 245,000 (Direct) |
View |
| 2023-02-24 Option Award |
2023-02-28 6:13 pm |
N/A 2033-02-23 |
Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer |
700,000 | $0 | 702,941 (Direct) |
View |
| 2022-12-15 Option Award |
2022-12-19 4:20 pm |
N/A 2032-12-14 |
Lyell Immunopharma Inc. | LYEL | Seely Lynn President and CEO |
7,500,000 | $0 | 7,500,000 (Direct) |
View |
| 2022-10-10 Option Award |
2022-10-12 4:10 pm |
N/A 2032-10-09 |
Lyell Immunopharma Inc. | LYEL | Thompson Rahsaan Chief Legal Officer |
715,000 | $0 | 715,000 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-09 4:05 pm |
N/A 2028-11-05 |
Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director |
145,380 | $0 | 4,709,844 (Direct) |
View |
| 2022-09-08 Exercise |
2022-09-09 4:05 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director |
145,380 | $0.1 | 4,709,844 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:20 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | RIEFLIN WILLIAM JL Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:18 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner |
65,000 | $0 | 36,477,716 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:16 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | Seely Lynn Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:14 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | NABEL ELIZABETH G Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:13 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | BRAWLEY OTIS W Director |
65,000 | $0 | 65,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:11 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director |
65,000 | $0 | 4,605,234 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:09 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | FRIEDMAN CATHY Director |
65,000 | $0 | 401,370 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:08 pm |
N/A 2032-06-07 |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Director |
65,000 | $0 | 4,032,834 (Direct) |
View |
Ownership |
2022-03-29 5:05 pm |
N/A 2030-08-09 |
Lyell Immunopharma Inc. | LYEL | Albertson Tina M. Chief Medical Officer |
0 | $0 | 1,500,000 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 4:11 pm |
N/A 2032-03-15 |
Lyell Immunopharma Inc. | LYEL | Turner Heather D Chief General Counsel |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 4:09 pm |
N/A 2032-03-15 |
Lyell Immunopharma Inc. | LYEL | Newton Charles W. Chief Financial Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 4:07 pm |
N/A 2032-03-15 |
Lyell Immunopharma Inc. | LYEL | Homans Elizabeth Chief Executive Officer |
1,479,500 | $0 | 1,479,500 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 4:05 pm |
N/A 2032-03-15 |
Lyell Immunopharma Inc. | LYEL | Hill Stephen J. Chief Technical Ops. Officer |
700,000 | $0 | 700,000 (Direct) |
View |
| 2022-02-23 Exercise |
2022-02-25 4:05 pm |
N/A 2028-11-05 |
Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director |
993,428 | $0 | 4,709,844 (Direct) |
View |
| 2022-02-23 Exercise |
2022-02-25 4:05 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director |
993,428 | $0.1 | 4,709,844 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-14 8:59 pm |
N/A 2032-02-10 |
Lyell Immunopharma Inc. | LYEL | Lee Gary K. Chief Scientific Officer |
800,000 | $0 | 800,000 (Direct) |
View |
| 2021-12-14 Other |
2021-12-14 4:57 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | FRIEDMAN CATHY Director |
3,984,564 | $0 | 4,320,934 (Indirect) |
View |
| 2021-09-13 Option Award |
2021-09-14 4:17 pm |
N/A 2031-09-12 |
Lyell Immunopharma Inc. | LYEL | Homans Elizabeth Chief Executive Officer |
1,370,469 | $0 | 1,370,469 (Direct) |
View |
| 2021-06-21 Conversion |
2021-06-23 6:14 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | GLAXOSMITHKLINE PLC 10% Owner |
30,253,189 | $0 | 30,253,189 (Indirect) |
View |
| 2021-06-21 Conversion |
2021-06-23 5:42 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | ARCH Venture Partners IX LLC ARCH Venture Fund IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner |
54,619,074 | $0 | 18,206,358 (Indirect) |
View |
| 2021-06-21 Conversion |
2021-06-23 5:38 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | NELSEN ROBERT Director 10% Owner |
54,619,074 | $0 | 18,206,358 (Indirect) |
View |
| 2021-06-21 Conversion |
2021-06-23 5:36 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | Klausner Richard Executive Chairman |
3,765,842 | $0 | 6,733,676 (Indirect) |
View |
| 2021-06-21 Conversion |
2021-06-23 5:35 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | Bishop Hans Edgar Director |
546,806 | $0 | 3,546,806 (Direct) |
View |
| 2021-06-21 Conversion |
2021-06-23 5:33 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | FRIEDMAN CATHY Director |
3,765,842 | $0 | 117,648 (Indirect) |
View |
Ownership |
2021-06-17 5:56 pm |
N/A N/A |
Lyell Immunopharma Inc. | LYEL | GLAXOSMITHKLINE PLC 10% Owner |
0 | $0 | 30,253,189 (Indirect) |
View |